Minjiang Chen

23PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical genetics (excl. cancer genetics)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 13, 2026
Divergent Tumor Immune Microenvironment and Response to Neoadjuvant Chemoimmunotherapy in Resectable Non-Small Cell Lung Cancer: A Single-Arm Phase II Trial.

|Feb 11, 2026
Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.

Minjiang Chen, Iurie Bulat, Marina Maglakelidze

|May 02, 2025
Real-World Analysis of Treatment Patterns in Limited-Stage Small Cell Lung Cancer: Implications for Clinical Practice.

Siyuan Yu, Xiaoyi Feng, Shengjie Li

|Mar 21, 2025
Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single-Arm Study.

Xiaoyi Feng, Xiaoyan Liu, Hui Guan

|Oct 29, 2024
Characterization of renal injury in non-squamous non-small cell lung cancer patients treated with pemetrexed: A single-center retrospective study.

Yang Wu, Kang Miao, Minjiang Chen

|Sep 29, 2024
Remarkable pathological response to neoadjuvant tepotinib in lung adenocarcinoma with MET exon 14 skipping mutation: A case report.

Rongzhen Li, Xiaoyan Liu, Yan Xu

Pageof 4

Frequent Collaborators

20 joint publications

Yan Xu

5 joint publications

Yuequan Shi

5 joint publications

Xiaoyan Si

5 joint publications

Xiaotong Zhang